Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Small Interfering | 8 | 2025 | 898 | 1.740 |
Why?
|
| Rabies virus | 3 | 2022 | 9 | 1.100 |
Why?
|
| Huntington Disease | 4 | 2024 | 152 | 1.090 |
Why?
|
| Rabies | 2 | 2021 | 8 | 0.900 |
Why?
|
| Nucleic Acids | 1 | 2024 | 60 | 0.830 |
Why?
|
| Oligonucleotides | 3 | 2023 | 219 | 0.750 |
Why?
|
| Phosphatidylcholines | 1 | 2021 | 35 | 0.750 |
Why?
|
| Molecular Imaging | 1 | 2021 | 48 | 0.720 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 305 | 0.660 |
Why?
|
| Mice | 20 | 2025 | 10804 | 0.570 |
Why?
|
| Ascorbic Acid | 3 | 2022 | 50 | 0.540 |
Why?
|
| Nitrogen Oxides | 1 | 2015 | 11 | 0.500 |
Why?
|
| Blood-Brain Barrier | 1 | 2015 | 85 | 0.470 |
Why?
|
| Animals | 22 | 2025 | 20581 | 0.440 |
Why?
|
| Contrast Media | 1 | 2015 | 421 | 0.400 |
Why?
|
| Oxidation-Reduction | 4 | 2025 | 325 | 0.390 |
Why?
|
| RNA, Messenger | 3 | 2025 | 1528 | 0.330 |
Why?
|
| Lysine | 2 | 2019 | 82 | 0.310 |
Why?
|
| Huntingtin Protein | 3 | 2024 | 141 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 8 | 2024 | 3387 | 0.290 |
Why?
|
| Alleles | 4 | 2022 | 445 | 0.280 |
Why?
|
| RNA Interference | 3 | 2025 | 618 | 0.270 |
Why?
|
| Brain | 1 | 2015 | 1550 | 0.270 |
Why?
|
| Superoxide Dismutase-1 | 2 | 2025 | 144 | 0.270 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 2147 | 0.250 |
Why?
|
| Factor VIII | 2 | 2023 | 32 | 0.250 |
Why?
|
| Volatile Organic Compounds | 1 | 2025 | 18 | 0.240 |
Why?
|
| Acetaminophen | 2 | 2025 | 59 | 0.240 |
Why?
|
| Podocytes | 1 | 2024 | 10 | 0.230 |
Why?
|
| Iron | 1 | 2025 | 146 | 0.230 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2024 | 8 | 0.220 |
Why?
|
| Integrin alpha5beta1 | 2 | 2023 | 6 | 0.220 |
Why?
|
| Capsid | 1 | 2024 | 96 | 0.220 |
Why?
|
| Liver | 3 | 2025 | 845 | 0.210 |
Why?
|
| Superoxide Dismutase | 2 | 2025 | 227 | 0.210 |
Why?
|
| Transduction, Genetic | 1 | 2024 | 236 | 0.210 |
Why?
|
| Organophosphorus Compounds | 1 | 2023 | 31 | 0.200 |
Why?
|
| Hemophilia A | 1 | 2023 | 57 | 0.200 |
Why?
|
| Lipids | 1 | 2025 | 316 | 0.200 |
Why?
|
| Peptide Initiation Factors | 2 | 2019 | 33 | 0.200 |
Why?
|
| Cartilage, Articular | 1 | 2023 | 76 | 0.200 |
Why?
|
| Liver Diseases | 1 | 2024 | 148 | 0.200 |
Why?
|
| PPAR alpha | 1 | 2022 | 34 | 0.200 |
Why?
|
| Viral Matrix Proteins | 1 | 2022 | 49 | 0.200 |
Why?
|
| Interleukin-15 | 1 | 2022 | 25 | 0.190 |
Why?
|
| Gene Transfer Techniques | 1 | 2024 | 315 | 0.190 |
Why?
|
| Central Nervous System | 1 | 2024 | 197 | 0.190 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2021 | 15 | 0.190 |
Why?
|
| Organophosphonates | 1 | 2021 | 22 | 0.190 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2021 | 28 | 0.190 |
Why?
|
| Osteoarthritis | 1 | 2023 | 140 | 0.190 |
Why?
|
| RAW 264.7 Cells | 1 | 2021 | 54 | 0.190 |
Why?
|
| Glutathione | 1 | 2021 | 55 | 0.190 |
Why?
|
| Apolipoprotein A-I | 1 | 2021 | 23 | 0.190 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2021 | 84 | 0.180 |
Why?
|
| Gene Silencing | 4 | 2025 | 392 | 0.180 |
Why?
|
| Phospholipids | 1 | 2021 | 81 | 0.180 |
Why?
|
| Aldehyde Reductase | 1 | 2021 | 4 | 0.180 |
Why?
|
| Corticosterone | 1 | 2021 | 23 | 0.180 |
Why?
|
| Fetal Growth Retardation | 1 | 2021 | 17 | 0.180 |
Why?
|
| Cell Nucleus | 1 | 2024 | 623 | 0.170 |
Why?
|
| Humans | 15 | 2025 | 62681 | 0.170 |
Why?
|
| Pregnancy-Specific beta 1-Glycoproteins | 1 | 2019 | 1 | 0.170 |
Why?
|
| Trophoblasts | 1 | 2019 | 5 | 0.170 |
Why?
|
| Polyamines | 1 | 2019 | 12 | 0.160 |
Why?
|
| Biomarkers | 2 | 2025 | 1385 | 0.160 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2025 | 507 | 0.160 |
Why?
|
| Dog Diseases | 1 | 2020 | 60 | 0.160 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 319 | 0.160 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2019 | 3 | 0.160 |
Why?
|
| RNA-Binding Proteins | 2 | 2019 | 432 | 0.160 |
Why?
|
| Genes, Recessive | 1 | 2019 | 52 | 0.150 |
Why?
|
| Adenosine Deaminase | 1 | 2018 | 19 | 0.150 |
Why?
|
| RNA Editing | 1 | 2018 | 23 | 0.150 |
Why?
|
| Genetic Vectors | 1 | 2024 | 851 | 0.150 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 40 | 0.150 |
Why?
|
| Insulin-Secreting Cells | 1 | 2019 | 190 | 0.150 |
Why?
|
| Dependovirus | 1 | 2024 | 695 | 0.150 |
Why?
|
| DNA | 1 | 2023 | 839 | 0.150 |
Why?
|
| RNA, Double-Stranded | 1 | 2018 | 111 | 0.140 |
Why?
|
| Mutation | 3 | 2024 | 2573 | 0.140 |
Why?
|
| Glucose | 1 | 2019 | 469 | 0.130 |
Why?
|
| Capillary Permeability | 1 | 2015 | 16 | 0.120 |
Why?
|
| Metabolic Clearance Rate | 1 | 2015 | 49 | 0.120 |
Why?
|
| Mice, Inbred C3H | 1 | 2015 | 176 | 0.120 |
Why?
|
| Tissue Distribution | 1 | 2015 | 293 | 0.120 |
Why?
|
| Image Enhancement | 1 | 2015 | 191 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 178 | 0.110 |
Why?
|
| Male | 7 | 2025 | 29486 | 0.110 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2018 | 425 | 0.110 |
Why?
|
| Mice, Knockout | 4 | 2022 | 2099 | 0.110 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 2174 | 0.100 |
Why?
|
| Computer Simulation | 1 | 2015 | 476 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 1139 | 0.100 |
Why?
|
| Caenorhabditis elegans | 1 | 2018 | 675 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1638 | 0.090 |
Why?
|
| Models, Biological | 1 | 2015 | 1180 | 0.080 |
Why?
|
| Viral Proteins | 2 | 2022 | 259 | 0.080 |
Why?
|
| Female | 6 | 2024 | 32491 | 0.080 |
Why?
|
| Lung | 2 | 2023 | 939 | 0.070 |
Why?
|
| Breath Tests | 1 | 2025 | 13 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2025 | 65 | 0.060 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2025 | 37 | 0.060 |
Why?
|
| Cathepsins | 1 | 2005 | 34 | 0.060 |
Why?
|
| alpha-Synuclein | 1 | 2025 | 35 | 0.060 |
Why?
|
| Kidney Tubules | 1 | 2024 | 21 | 0.060 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2025 | 77 | 0.060 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2024 | 25 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 1 | 2005 | 94 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2025 | 1271 | 0.060 |
Why?
|
| Antigen-Presenting Cells | 1 | 2005 | 178 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2025 | 256 | 0.060 |
Why?
|
| Protein Binding | 2 | 2019 | 1601 | 0.060 |
Why?
|
| Fatty Liver | 1 | 2025 | 108 | 0.060 |
Why?
|
| trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride | 1 | 2024 | 1 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2005 | 182 | 0.060 |
Why?
|
| tau Proteins | 1 | 2025 | 201 | 0.050 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2023 | 7 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2024 | 109 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2025 | 212 | 0.050 |
Why?
|
| Chondrocytes | 1 | 2023 | 42 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 262 | 0.050 |
Why?
|
| Integrins | 1 | 2023 | 109 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2005 | 235 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2024 | 128 | 0.050 |
Why?
|
| Pregnancy | 2 | 2021 | 2316 | 0.050 |
Why?
|
| Chemical Engineering | 1 | 2022 | 9 | 0.050 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2022 | 15 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2023 | 112 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 224 | 0.050 |
Why?
|
| Endosomes | 1 | 2023 | 178 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2022 | 92 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 129 | 0.050 |
Why?
|
| Vitamins | 1 | 2022 | 81 | 0.050 |
Why?
|
| Immune Tolerance | 1 | 2023 | 175 | 0.050 |
Why?
|
| Sirolimus | 1 | 2022 | 91 | 0.050 |
Why?
|
| Interferons | 1 | 2022 | 74 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2023 | 159 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2022 | 152 | 0.050 |
Why?
|
| Amino Acids | 1 | 2022 | 146 | 0.050 |
Why?
|
| Thermogenesis | 1 | 2022 | 120 | 0.050 |
Why?
|
| Ribonucleoproteins | 1 | 2022 | 114 | 0.050 |
Why?
|
| Adipose Tissue, Brown | 1 | 2022 | 117 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 288 | 0.050 |
Why?
|
| Blood Cell Count | 1 | 2021 | 33 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2022 | 272 | 0.040 |
Why?
|
| Tokyo | 1 | 2020 | 1 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 213 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 336 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2021 | 236 | 0.040 |
Why?
|
| Ornithine Decarboxylase | 1 | 2019 | 10 | 0.040 |
Why?
|
| Cyclin D2 | 1 | 2019 | 7 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2023 | 321 | 0.040 |
Why?
|
| Heparitin Sulfate | 1 | 2019 | 11 | 0.040 |
Why?
|
| Immobilized Proteins | 1 | 2019 | 6 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 422 | 0.040 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2019 | 16 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2019 | 109 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2019 | 26 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2020 | 133 | 0.040 |
Why?
|
| RNA | 1 | 2023 | 422 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2019 | 103 | 0.040 |
Why?
|
| Placenta | 1 | 2019 | 58 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2019 | 207 | 0.040 |
Why?
|
| Phylogeny | 1 | 2020 | 366 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 102 | 0.040 |
Why?
|
| Dogs | 1 | 2020 | 324 | 0.040 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2019 | 20 | 0.040 |
Why?
|
| Inosine | 1 | 2018 | 4 | 0.040 |
Why?
|
| Deamination | 1 | 2018 | 11 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 198 | 0.040 |
Why?
|
| Haplotypes | 1 | 2019 | 118 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2018 | 100 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 139 | 0.040 |
Why?
|
| Pre-Eclampsia | 1 | 2019 | 72 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2019 | 174 | 0.040 |
Why?
|
| Pedigree | 1 | 2019 | 193 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2019 | 303 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2023 | 866 | 0.040 |
Why?
|
| Adenosine | 1 | 2018 | 78 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2024 | 771 | 0.040 |
Why?
|
| Seizures | 1 | 2019 | 144 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 289 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2018 | 337 | 0.040 |
Why?
|
| Cell Movement | 1 | 2019 | 445 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 113 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 718 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2019 | 493 | 0.030 |
Why?
|
| Homeostasis | 1 | 2019 | 367 | 0.030 |
Why?
|
| Phenotype | 1 | 2020 | 1193 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2019 | 981 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 1594 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2038 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 761 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2019 | 1937 | 0.030 |
Why?
|
| Child | 1 | 2019 | 4444 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 4633 | 0.020 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2005 | 9 | 0.020 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2005 | 13 | 0.020 |
Why?
|
| Cathepsin L | 1 | 2005 | 21 | 0.020 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2005 | 24 | 0.020 |
Why?
|
| Myelin Proteins | 1 | 2005 | 30 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2005 | 116 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2005 | 140 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2005 | 216 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2005 | 248 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 14255 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 17364 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2005 | 641 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2005 | 1346 | 0.010 |
Why?
|